Edgen Stock·Dec 17 2025, 10:34Back
Immutep Lung Cancer Trial Hits 38% Enrollment Milestone
Edgen Stock·Dec 17 2025, 10:34
[1] Immutep Announces Strong Operational Progress in Global TACTI-004 (KEYNOTE-F91) Phase III and Enrolment Continues at Robust Pace (https://finance.yahoo.com/news/immutep-announ ...)
